cilomilast has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fortescue, R; Janjua, S; Poole, P | 1 |
| Chong, J; Leung, B; Poole, P | 1 |
| Amparo, F; Chauhan, SK; Chen, Y; Dana, R; Dohlman, TH; Hua, J; Okanobo, A; Sadrai, Z; Stevenson, W | 1 |
2 review(s) available for cilomilast and Disease Exacerbation
| Article | Year |
|---|---|
Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aminopyridines; Benzamides; Cyclohexanecarboxylic Acids; Cyclopropanes; Diarrhea; Disease Progression; Forced Expiratory Volume; Humans; Middle Aged; Nitriles; Peak Expiratory Flow Rate; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Thiazoles; Vital Capacity | 2020 |
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aminopyridines; Benzamides; Cyclohexanecarboxylic Acids; Cyclopropanes; Disease Progression; Forced Expiratory Volume; Humans; Nitriles; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic | 2017 |
1 other study(ies) available for cilomilast and Disease Exacerbation
| Article | Year |
|---|---|
PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease.
Topics: Animals; Conjunctiva; Cornea; Cyclohexanecarboxylic Acids; Disease Models, Animal; Disease Progression; Dry Eye Syndromes; Female; Flow Cytometry; Gene Expression Regulation; Immunity, Innate; Immunohistochemistry; Interleukin-7; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Nitriles; Ophthalmic Solutions; Phosphodiesterase 4 Inhibitors; Real-Time Polymerase Chain Reaction; RNA | 2012 |